12:52 PM EDT, 06/03/2024 (MT Newswires) -- The European Commission is unlikely to seek feedback to remedies the European Energy Exchange submitted to address antitrust concerns on EEX's acquisition of Nasdaq's (NDAQ) European power trading and clearing business, Reuters reported Monday. That signals the remedies are insufficient, the report said, citing people with direct knowledge of the matter. EU antitrust...

12:49 PM EDT, 06/03/2024 (MT Newswires) -- National Bank has cut Laurentian Bank's target to $26 (from $27), and maintained its Underperform rating. Laurentian reported Q2/24 core cash EPS of $0.90 vs. NBF $0.90 and consensus of $0.88. Analyst Gabriel Dechaine writes that while Laurentian's results met expectations on an adjusted basis, the reported figure was the real focus. Laurentian...

12:51 PM EDT, 06/03/2024 (MT Newswires) -- Structure Therapeutics ( GPCR ) shares were up about 63% in recent Monday trading after the company reported positive 12-week topline obesity data from its phase 2a trial of GSBR-1290, with results showing a clinically meaningful and statistically significant placebo-adjusted mean weight loss of 6.2%. The capsule to tablet pharmacokinetics study also yielded...

Bristol Myers Squibb & Co ( BMY )  announced on Saturday (June 1) results from the Phase 3 KRYSTAL-12 study evaluating Krazati (adagrasib) compared to standard-of-care chemotherapy for locally advanced or metastatic KRASG12C-mutated non-small cell lung cancer (NSCLC) which previously received platinum-based chemotherapy, concurrently or sequentially with anti-PD-(L)1 therapy. At a median follow-up of 9.4 months, Krazati demonstrated a statistically significant and clinically meaningful...